Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-412,038
Closed -$14.1M 4813
2018
Q1
$13.9M Buy
+412,038
New +$14.2M 0.06% 330
2017
Q1
Sell
-167,936
Closed -$5.29M 4832
2016
Q4
$5.17M Buy
167,936
+73,166
+77% +$2.23M 0.04% 690
2016
Q3
$3.04M Buy
+94,770
New +$3.17M 0.02% 996
2016
Q1
Sell
-39,137
Closed -$1.2M 4897
2015
Q4
$1.2M Buy
39,137
+33,932
+652% +$1.07M 0.01% 1768
2015
Q3
$155K Sell
5,205
-308,498
-98% -$9.89M ﹤0.01% 3961
2015
Q2
$9.98M Buy
+313,703
New +$10.2M 0.06% 436
2014
Q3
Sell
-82,270
Closed -$2.31M 5049
2014
Q2
$2.32M Sell
82,270
-68,062
-45% -$1.94M 0.02% 978
2014
Q1
$4.58M Buy
150,332
+68,542
+84% +$2.04M 0.04% 684
2013
Q4
$2.38M Sell
81,790
-16,321
-17% -$475K 0.02% 1304
2013
Q3
$1.34M Sell
98,111
-448,343
-82% -$12.2M 0.01% 1887
2013
Q2
$14.5K Buy
+546,454
New +$15.1M 0.05% 189

Other funds holding PFE

PEAK6 Group's PFE Position: Q2 2018 in Review

PEAK6 Group sold out of Pfizer (PFE) in Q2 2018, closing a stake of 412,038 shares — an estimated $14.1M sold.

PEAK6 Group first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $13.9M in Q1 2018. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • PEAK6 Group reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 412,038 Pfizer shares in Q2 2018, an estimated $14.1M.
  • PEAK6 Group first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • PEAK6 Group's Pfizer position peaked at $13.9M in Q1 2018.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.